AstraZeneca's ovarian cancer drug gets U.S. approval

December 19, 2014 5:37 PM

4 0

AstraZeneca's ovarian cancer drug gets U.S. approval

(Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.

An advisory panel to the U.S. Food and Drug Administration had voted in June against granting an accelerated approval to the drug, Lynparza, citing inadequate data.

Read more

To category page

Loading...